Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ascorbic acid and post-operative endothelial function after abdominal aortic aneurysm repair
2006-006887-44Phase 2Completed
- Sponsor
- Royal Group of Hospitals
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ascorbic acid in abdominal aortic aneurysm (AAA) and abdominal aortic rupture (rAAA), sponsored by Royal Group of Hospitals. Primary endpoints: Change in systemic endothelial function and Change in pulmonary endothelial function. Started May 2007; status: completed.
02
Drugs
ascorbic acid
03
Conditions
abdominal aortic aneurysm (AAA)abdominal aortic rupture (rAAA)
Beyond the preview
Go deeper on 2006-006887-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006887-44.